Evidence map›Paper›PMID 36200916›Full record

ArticleToxicological sciences : an official journal of the Society of Toxicology2023

The imprinted gene Zac1 regulates steatosis in developmental cadmium-induced nonalcoholic fatty liver disease.

Sierra D Riegl, Cassie Starnes, Dereje D Jima, Marine Baptissart, Anna Mae Diehl, Scott M Belcher, Michael Cowley

Open access · greenAbstract read
In one paragraph

Article in Toxicological sciences : an official journal of the Society of Toxicology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 22 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Sierra D RieglCenter for Human Health and the Environment, North Carolina State University, Raleigh, North Carolina 27695, USA.
Cassie StarnesCenter for Human Health and the Environment, North Carolina State University, Raleigh, North Carolina 27695, USA.
Dereje D JimaCenter for Human Health and the Environment, North Carolina State University, Raleigh, North Carolina 27695, USA.
Marine BaptissartCenter for Human Health and the Environment, North Carolina State University, Raleigh, North Carolina 27695, USA.
Anna Mae DiehlDepartment of Medicine, Duke University, Durham, North Carolina 27710, USA.
Scott M BelcherCenter for Human Health and the Environment, North Carolina State University, Raleigh, North Carolina 27695, USA.ORCID 0000-0002-1196-3705
Michael CowleyCenter for Human Health and the Environment, North Carolina State University, Raleigh, North Carolina 27695, USA.ORCID 0000-0001-8564-4224
North Carolina State University · USDuke University · US

Funding

Translational Research Support CoreP30ES025128 · NIEHS · NORTH CAROLINA STATE UNIVERSITY RALEIGH · PI Kelly Sides · 2015 to 2026
$18.3M
TRAINING IN BIOCHEMICAL AND ENVIRONMENTAL TOXICOLOGYT32ES007046 · NIEHS · NORTH CAROLINA STATE UNIVERSITY RALEIGH · PI Seth William Kullman · 1985 to 2026
$5.1M
The Imprinted Gene Network in the Programming of Non-Alcoholic Fatty Liver Disease by Early Life Cadmium ExposureR01ES031596 · NIEHS · NORTH CAROLINA STATE UNIVERSITY RALEIGH · PI COWLEY, MICHAEL · 2020 to 2024
$1.8M
Epigenetic mechanisms linking in utero cadmium exposure to hepatic steatosisK22ES027510 · NIEHS · NORTH CAROLINA STATE UNIVERSITY RALEIGH · PI COWLEY, MICHAEL · 2017 to 2019
$485k
NIEHS NIH HHS K22 ES027510NIEHS NIH HHS P30 ES025128NIEHS NIH HHS R01 ES031596NIEHS NIH HHS T32 ES007046
6 · The paper itself

Abstract

Cadmium (Cd) exposure in adulthood is associated with nonalcoholic fatty liver disease (NAFLD), characterized by steatosis, inflammation, and fibrosis. The prevalence of NAFLD in children is increasing, suggesting a role for the developmental environment in programming susceptibility. However, the role of developmental Cd exposure in programming NAFLD and the underlying mechanisms remain unclear. We have proposed that imprinted genes are strong candidates for connecting the early life environment and later life disease. In support of this, we previously identified roles for the Imprinted Gene Network (IGN) and its regulator Zac1 in programming NAFLD in response to maternal metabolic dysfunction. Here, we test the hypothesis that developmental Cd exposure is sufficient to program NAFLD, and further, that this process is mediated by Zac1 and the IGN. Using mice, we show that developmental cadmium chloride (CdCl2) exposure leads to histological, biochemical, and molecular signatures of steatosis and fibrosis in juveniles. Transcriptomic analyses comparing livers of CdCl2-exposed and control mice show upregulation of Zac1 and the IGN coincident with disease presentation. Increased hepatic Zac1 expression is independent of promoter methylation and imprinting statuses. Finally, we show that over-expression of Zac1 in cultured hepatocytes is sufficient to induce lipid accumulation in a Pparγ-dependent manner and demonstrate direct binding of Zac1 to the Pparγ promoter. Our findings demonstrate that developmental Cd exposure is sufficient to program NAFLD in later life, and with our previous work, establish Zac1 and the IGN as key regulators of prosteatotic and profibrotic pathways, two of the major pathological hallmarks of NAFLD.

Indexed as

Non-alcoholic Fatty Liver DiseaseAnimalsCadmiumCadmium ChlorideFibrosisLiverMicePPAR gammaCadmiumCadmium ChloridePPAR gammacadmiumdevelopmental programmingdevelopmental toxicologyepigeneticsgenomic imprintingnonalcoholic fatty liver disease

Identifiers

PMID36200916
PMCPMC9887675
OpenAlexW4302304624

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.